![Comparing the frequency of isotretinoin-induced hair loss at <0.5-mg/kg/d versus ≥0.5-mg/kg/d dosing in acne patients: A systematic review - JAAD International Comparing the frequency of isotretinoin-induced hair loss at <0.5-mg/kg/d versus ≥0.5-mg/kg/d dosing in acne patients: A systematic review - JAAD International](https://www.jaadinternational.org/cms/asset/8cbcafa3-00cb-4b53-8125-9c27b037ce9f/gr1.jpg)
Comparing the frequency of isotretinoin-induced hair loss at <0.5-mg/kg/d versus ≥0.5-mg/kg/d dosing in acne patients: A systematic review - JAAD International
![Oral isotretinoin in different dose regimens for acne vulgaris: A randomized comparative trial - Indian Journal of Dermatology, Venereology and Leprology Oral isotretinoin in different dose regimens for acne vulgaris: A randomized comparative trial - Indian Journal of Dermatology, Venereology and Leprology](https://ijdvl.com/content/126/2011/77/6/Images/ijdvl_2011_77_6_688_86482_t6.jpg)
Oral isotretinoin in different dose regimens for acne vulgaris: A randomized comparative trial - Indian Journal of Dermatology, Venereology and Leprology
![The use of isotretinoin in the treatment of acne vulgaris: clinical considerations and future directions. - Abstract - Europe PMC The use of isotretinoin in the treatment of acne vulgaris: clinical considerations and future directions. - Abstract - Europe PMC](https://europepmc.org/articles/PMC3970835/bin/jcad_7_2_suppl-g004.jpg)
The use of isotretinoin in the treatment of acne vulgaris: clinical considerations and future directions. - Abstract - Europe PMC
![Isotretinoin | CAS:4759-48-2 | Inducer of neuronal differentiation; endogenous agonist for retinoic acid receptors | High Purity | Manufacturer BioCrick Isotretinoin | CAS:4759-48-2 | Inducer of neuronal differentiation; endogenous agonist for retinoic acid receptors | High Purity | Manufacturer BioCrick](https://www.biocrick.com/media/images/struct/BCC2284.png)
Isotretinoin | CAS:4759-48-2 | Inducer of neuronal differentiation; endogenous agonist for retinoic acid receptors | High Purity | Manufacturer BioCrick
![Low‐dose oral isotretinoin for the treatment of adult patients with mild‐to‐moderate acne vulgaris: Systematic review and meta‐analysis - Al Muqarrab - 2022 - Dermatologic Therapy - Wiley Online Library Low‐dose oral isotretinoin for the treatment of adult patients with mild‐to‐moderate acne vulgaris: Systematic review and meta‐analysis - Al Muqarrab - 2022 - Dermatologic Therapy - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/78d76e00-b017-44c6-9e35-63f4e8d06a23/dth15311-fig-0005-m.jpg)